Journal of
Diabetes and Endocrinology

  • Abbreviation: J. Diabetes Endocrinol.
  • Language: English
  • ISSN: 2141-2685
  • DOI: 10.5897/JDE
  • Start Year: 2010
  • Published Articles: 65

Full Length Research Paper

Usefulness of urinary fibronectin and laminin as biomarkers of glomerular injury in diabetics in Port Harcourt, Nigeria

Michael Chinwe Orih
  • Michael Chinwe Orih
  • Department of Chemical Pathology, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria.
  • Google Scholar
Christopher Chinedu Obiorah
  • Christopher Chinedu Obiorah
  • Department of Anatomical Pathology, University of Port Harcourt Teaching Hospital, Port Harcourt, Rivers State, Nigeria.
  • Google Scholar


  •  Received: 12 February 2020
  •  Accepted: 09 April 2020
  •  Published: 31 May 2020

References

Agaba EI, Agaba PA, Puepet FH (2004). Prevalence of microalbuminuria in newly diagnosed type 2 diabetic patients in Jos Nigeria. African Journal of Medicine and Medical Sciences 33:19-22.

 

Akinkugbe OO, Ikeme AC, Johnson TO (1997). Non-communicable diseases in Nigeria.Final Report of National Survey, Federal Ministry of Health and Social Services, Lagos,pp.64-90.

 

Alebiosu CO, Ayodele OE (2005). The global burden of chronic kidney disease and the way forward. Ethnicity and Disease 15:418-423.

 

Alwan A (2011). Global status report on noncommunicable diseases 2010.World Health Organization. 

View

 

An JH, Cho YM, Yu HG, Jang HC, Park KS, Kim SY, Lee HK (2009). The clinical characteristics of normoalbuminuric renal insufficiency in Korean type 2 diabetic patients: a possible early stage renal complication. Journal of Korean Medical Science, 24:S75-S81.
Crossref

 

Andermann A, Blancquaert I, Beauchamp S, Déry V (2008). Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bulletin of World Health Organization 86:317-319.
Crossref

 

Araoye MO (2004). Research Methodology with Statistics for Health and Social Sciences, first edition. Nathadex publishers, Ilorin: pp. 25-120

 

Brentnall M, Weir DB, Rongvaux A, Marcus AI, Boise LH (2014). Procaspase-3 regulates fibronectin secretion and influences adhesion, migration and survival independently of catalytic function. Journal of Cell Science 127:2217-2226.
Crossref

 

De Zeeuw D, Ramjit D, Zhang Z, Ribeiro AB, Kurokawa K, Lash JP, Chan J, Remuzzi G, Brenner BM, Shahinfar S (2006). Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. Kidney international 69:1675-1682.
Crossref

 

Dods R (2010). Diabetes Mellitus In: Clinical Chemistry: Theory, Analysis, Correlation , St. Louis, Missouri, Mosby. pp 729-754.

 

Elving LD, Bakkeren JA, Jansen MJ, de Kat Angelino CM, de Nobel E, van Munster PJ (1989). Screening for microalbuminuria in patients with diabetes mellitus: frozen storage of urine samples decreases their albumin content. Clinical Chemistry 35:308-310.
Crossref

 

Fagerudd JA, Groop PH, Honkanen E, Teppo AM, Grönhagen-Riska C (1997).Urinary excretion of TGF-β1, PDGF-BB and fibronectin in insulin-dependent diabetes mellitus patients. Kidney International Supplement 63:195-197.

 

Hellemons ME, Kerschbaum J, Bakker SJL, Neuwirt H, Mayer B, Mayer G, de Zeeuw D, LambersHeerspink HJ, Rudnicki M (2012). Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review. Medication Diabetes 29:567-577.
Crossref

 

Hong CY, Chia KS (1998).Markers of diabetic nephropathy.Journal of Diabetes and its Complications 12:43-60.
Crossref

 

Hosseinpoor AR, Stewart Williams J, Amin A, Araujo de Carvalho I, Beard J, Boerma T, Kowal P, Naidoo N, Chatterji S (2012). Social determinants of self-reported health in women and men: understanding the role of gender in population health. PLoS ONE 7:e34799.
Crossref

 

Kanakamani J, Ammini AC, Gupta N, Dwivedi SN (2010). Prevalence of microalbuminuria among patients with type 2 diabetes mellitus--a hospital-based study from north India.Diabetes Technology and Therapeutics 12:161-166.
Crossref

 

Kleinman HK, Cannon FB, Laurie GW, Hassell JR, Aumailley M, Terranova VP, Martin GR, DuBois-Dalcq M (1985). Biological activities of laminin. Journal of Cellular Biochemistry 27:317-325.
Crossref

 

Lehmann R, Schleicher ED (2000). Molecular mechanism of diabetic nephropathy. Clinica Chimica Acta, 297:135-144.
Crossref

 

Lott JA, Mitchell LC, Moeschberger ML, Sutherland DE (1992). Estimation of reference ranges: how many subjects are needed? Clinical Chemistry 38:648-650.
Crossref

 

Lynch KL, Wu AHB (2010). Renal Function In: Clinical Chemistry: Principles, Techniques, and Correlations, New York, Lippincott Williams & Wilkins. pp. 557-597.

 

Mario UD, Morano S, Cancelli A, Bacci S, Frontoni S, Pietravalle P, Gambardella S, Andreani D (1989). New Parameters to Monitor the Progression of Diabetic Nephropathy. American Journal of Kidney Diseases 13:45-48.
Crossref

 

Matheson A, Willcox MDP, Flanagan J, Walsh BJ (2010). Urinary biomarkers involved in type 2 diabetes: a review. Diabetes-Metabolism Research and Reviews, 26:150-171.
Crossref

 

Miyake H, Nagashima K, Yagi H, Onigata K (1993). Urinary laminin P1 as an index of glycemic control in children with insulin-dependent diabetes mellitus. Diabetes research (Edinburgh, Scotland) 23:131-138.

 

Naresh VVS, Reddy ALK, Sivaramakrishna G, Sharma PVGK, Vardhan RV, Kumar VS (2009).Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy.Indian Journal of Nephrology 19:145-148.
Crossref

 

Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen C-E, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J, ADVANCE Collaborative Group (2009). Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. Journal of the American Society of Nephrology 20:1813-1821.
Crossref

 

Nyenwe EA, Odia OJ, Ihekwaba AE, Ojule A, Babatunde S (2003). Type 2 diabetes in adult Nigerians: a study of its prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Research and Clinical Practice 62:177-185.
Crossref

 

Ogbu ISL, Iheanacho CP, Ofoegbu EN (2009). The Prevalence of Microalbuminuria in Type 2 Diabetic Patients in Enugu Metropolis.Journal of College of Medicine, 14(2).unpaginated.

 

Oputa RN, Chinenye S (2015). Diabetes in Nigeria-A translational medicine approach. African Journal of Diabetes Medicine,23:7-10.

 

Orluwene CG, Mommoh MO (2008).Screening for microalbuminuria in newly diagnosed type 2 diabetics at a staff clinic in Port Harcourt. Port Harcourt Medical Journal 3:10-14.
Crossref

 

Parchwani DN, Upadhyah AA (2012). Diabetic nephropathy: Progression and pathophysiology. International Journal of Medicine and Public Health 1:59-70.
Crossref

 

Remuzzi G, Schieppati A, Ruggenenti P (2002). Clinical practice.Nephropathy in patients with type 2 diabetes. New England Journal of Medicine 346:1145-1151.
Crossref

 

Takahashi M (1995) Increased urinary fibronectin excretion in type II diabetic patients with microalbuminuria. Nihon JinzoGakkai Shi 37:336-342.

 

Vasiliades J (1976). Reaction of alkaline sodium picrate with creatinine: I. Kinetics and mechanism of formation of the mono-creatinine picric acid complex. Clinical Chemistry 22:1664-1671.
Crossref

 

Weissman M, Klein B (1958). Evaluation of glucose determinations in untreated serum samples.Clinical Chemistry 4:420-422.
Crossref

 

Whiting DR, Guariguata L, Weil C, Shaw J (2011). IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 94:311-321.
Crossref

 

Yamazaki M, Tani N, Igarashi K, Nakamura H, Momotsu T, Ito S, Shibata A (1991). Changes in the glomerular pore size selectivity in patients with type II diabetes mellitus. Journal of Diabetic Complications, Proceedings of the International Symposium on Diabetic Nephropathy 5:138-139.
Crossref